Uma rede global para a promoção dum debate aberto e objetivo sobre a política de drogas
On June 26th, groups of 100 or more campaign supporters will gather in key cities around the world for a coordinated 'day of action'. They will all be wearing Support. Don't Punish. t-shirts and Richard Nixon masks.
Students for Sensible Drug Policy UK (SSDP) will participate in the Support. Don't Punish Global Day of Action on Wednesday 26th June 2013, that will take place in more than 20 cities, including London.
Human Rights Watch disse que políticas públicas que impõem sanções criminais para o consumo pessoal de drogas minam direitos humanos básicos e apela os governos contar com políticas reguladoras não criminais e de saúde pública.
The discussion will include representatives from governmental and international bodies, academia and civil society in a multi-disciplinary dialogue on the nature and extent of women’s participation in the cultivation, production, distribution and utilization of drugs in the Americas.
Global Commission on Drug Policy calls for decriminalization of drug use and expansion of proven, science-based solutions to reduce Hepatitis C – Including sterile syringe access, safer injection facilities and prescription heroin programs.
These scenarios are stories about what 'could' happen in the future in and around the hemispheric drug system, based on current trends, and including relevant political, economic, social, cultural and international dynamics.
This report contains recommendations for federal legislative reform related to civil rights, deficit reduction, law enforcement, foreign policy, sentencing, effective drug treatment, public health, and drug prevention education.
The review was mandated by Heads of State at 2012 Summit of the Americas. The new study should enrich the already-vibrant hemispheric debate over drug policy alternatives, including the option of legal, regulated markets for cannabis.
After analysing the regional debate and national-level reforms, this report concludes with policy recommendations that should be undertaken to maintain the momentum and advance drug policy reforms in the region.